Arkolith/Insider Trading/OCEL/Form 4

Sinnreich Matthew Phillip

President and Acting CEO, DirectorOrganicell Regenerative Medicine, Inc. (OCEL) · full profile →Form 4 · filed Oct 17, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$800
Net Open-Market Flow
-$800
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 13, 2022Sell(S)20K$0.04$8007.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001829126-22-017985) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML